by Nature
Building on the success of their T-cell receptor-mimic antibody (TCR-m) targeting the signal peptide CG1, scientists applied a similar construct to the development of chimeric antigen receptor...
by Blood
Research confirms the contribution of CD47 upregulation to the development of graft-versus-host disease (GVHD) following allogeneic hematopoietic cell transplantation (allo-HCT) and supports...
by Nature
Evidence suggests that adding both a calcineurin inhibitor (CNI) and mycophenolate mofetil (MMF) to post-transplant cyclophosphamide (PTCy) may help prevent a common complication after HLA-matched...
by Blood Advances
Registry data suggest post-transplant cyclophosphamide (PTCy) is safe and effective for patients with severe aplastic anemia (SAA) who undergo stem cell transplantation (SCT), especially with...
by Blood Advances
Patients who have myeloid malignancies with TP53 mutations often fare poorly after hematopoietic stem cell transplantation (HSCT), but researchers say certain prognostic factors can help identify...
by Rahul Banerjee, MD, FACP
One of the most predictable toxicities of autologous stem cell transplantation (ASCT) for multiple myeloma (MM) — even more so than mucositis — is hair loss.